531624 Stock Overview
Engages in the real estate business in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Country Condo's Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹6.06 |
| 52 Week High | ₹8.63 |
| 52 Week Low | ₹4.45 |
| Beta | 1.38 |
| 11 Month Change | -0.98% |
| 3 Month Change | -24.44% |
| 1 Year Change | 26.25% |
| 33 Year Change | 83.64% |
| 5 Year Change | 285.99% |
| Change since IPO | -39.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531624 | IN Real Estate | IN Market | |
|---|---|---|---|
| 7D | -3.3% | 4.2% | 0.5% |
| 1Y | 26.3% | 42.1% | 27.5% |
Return vs Industry: 531624 underperformed the Indian Real Estate industry which returned 38.4% over the past year.
Return vs Market: 531624 matched the Indian Market which returned 25.5% over the past year.
Price Volatility
| 531624 volatility | |
|---|---|
| 531624 Average Weekly Movement | 6.2% |
| Real Estate Industry Average Movement | 6.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 531624 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 531624's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 76 | Datla Krishna Raju | www.countrycondos.co.in |
Country Condo's Limited engages in the real estate business in India. The company develops and sells residential layouts; and constructs compound walls, etc. It also undertakes construction and sale of condos. The company was formerly known as Neocure Therapeutics Ltd.
Country Condo's Limited Fundamentals Summary
| 531624 fundamental statistics | |
|---|---|
| Market cap | ₹464.03m |
| Earnings (TTM) | ₹6.75m |
| Revenue (TTM) | ₹212.47m |
68.7x
P/E Ratio2.2x
P/S RatioIs 531624 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531624 income statement (TTM) | |
|---|---|
| Revenue | ₹212.47m |
| Cost of Revenue | ₹92.57m |
| Gross Profit | ₹119.90m |
| Other Expenses | ₹113.15m |
| Earnings | ₹6.75m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.087 |
| Gross Margin | 56.43% |
| Net Profit Margin | 3.18% |
| Debt/Equity Ratio | 6.1% |
How did 531624 perform over the long term?
See historical performance and comparison